toxoidum tetani min. 20 U.I., toxoidum diphtheriae min. 2 U.I., virus poliomyelitis typus 1 inactivatus 29 U., virus poliomyelitis typus 2 inactivatus 7 U., virus poliomyelitis typus 3 inactivatus 26 U., aluminium 0.35 mg ut aluminii hydroxidum hydricum ad adsorptionem, formaldehydum, medium 199 cum phenylalaninum 12.5 µg, phenoxyethanolum, ethanolum anhydricum 2 mg, acidum hydrochloridum, natrii hydroxidum, acidum aceticum, aqua ad iniectabile, ad suspensionem pro 0.5 ml corresp., kalium 0.12 mg et natrium 1.6 mg, residui: neomycinum, streptomycinum, polymyxinum B.
Packungsbestandteile
Injection suspension
Active Agent
Dose
Toxoidum Diphtheriae
2U.I. / 0.5ml
Toxoidum Tetani
20U.I. / 0.5ml
BAG: Active Agent
Dose
Toxoidum Diphtheriae
2 UI
Toxoidum Tetani
20 UI
Vaccinum Poliomyelitidis Inactivatum (Salk typ I, II, III)
62 U
Inactive agents
Dose
Acetic Acid
Acidum Hydrochloridum
Alumine
0.35mg / 0.5ml
Cum Phenylalaninum
12.5µg / 0.5ml
Ethanol Anhydrate
2mg / 0.5ml
Formaldehydum
Inactivatus
26U. / 0.5ml
Medium
199
Sodium Hydroxide
Phenoxyethanol
Virus Poliomyelitis Typus
3
Source
Data was imported : 06.02.2024
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
